Ultragenyx Pharmaceutical, Inc. (RARE)
16.10
-0.68
(-4.05%)
USD |
NASDAQ |
Oct 30, 16:00
16.09
-0.01
(-0.06%)
After-Hours: 20:00
Ultragenyx Pharmaceutical 30-Day Average Daily Volume : 3.919M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 3.919M |
| October 29, 2026 | 4.286M |
| October 28, 2026 | 4.606M |
| October 27, 2026 | 4.697M |
| October 26, 2026 | 4.720M |
| October 23, 2026 | 4.817M |
| October 22, 2026 | 4.866M |
| October 21, 2026 | 4.909M |
| October 20, 2026 | 4.967M |
| October 19, 2026 | 5.047M |
| October 16, 2026 | 5.330M |
| October 15, 2026 | 6.138M |
| October 14, 2026 | 6.266M |
| October 13, 2026 | 6.230M |
| October 12, 2026 | 6.118M |
| October 09, 2026 | 6.075M |
| October 08, 2026 | 6.015M |
| October 07, 2026 | 5.891M |
| October 06, 2026 | 5.879M |
| October 05, 2026 | 5.801M |
| October 02, 2026 | 5.725M |
| October 01, 2026 | 5.724M |
| September 30, 2026 | 5.682M |
| September 29, 2026 | 5.594M |
| September 28, 2026 | 5.442M |
| Date | Value |
|---|---|
| September 25, 2026 | 5.318M |
| September 24, 2026 | 5.206M |
| September 23, 2026 | 5.141M |
| September 22, 2026 | 5.022M |
| September 21, 2026 | 4.829M |
| September 18, 2026 | 4.781M |
| September 17, 2026 | 4.402M |
| September 16, 2026 | 4.076M |
| September 15, 2026 | 3.978M |
| September 14, 2026 | 3.859M |
| September 11, 2026 | 3.713M |
| September 10, 2026 | 3.694M |
| September 09, 2026 | 3.649M |
| September 08, 2026 | 3.558M |
| September 04, 2026 | 3.420M |
| September 03, 2026 | 3.086M |
| September 02, 2026 | 2.244M |
| September 01, 2026 | 2.056M |
| August 31, 2026 | 2.070M |
| August 28, 2026 | 2.047M |
| August 27, 2026 | 2.044M |
| August 26, 2026 | 2.066M |
| August 25, 2026 | 2.045M |
| August 24, 2026 | 1.954M |
| August 21, 2026 | 1.949M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ionis Pharmaceuticals, Inc. | 3.114M |
| AbbVie, Inc. | 4.796M |
| Krystal Biotech, Inc. | 262175.4 |
| BridgeBio Pharma, Inc. | 2.958M |
| Alnylam Pharmaceuticals, Inc. | 1.861M |